» Articles » PMID: 25008767

Whole Exome Sequencing Reveals That the Majority of Schwannomatosis Cases Remain Unexplained After Excluding SMARCB1 and LZTR1 Germline Variants

Citing Articles

Optimal Delivery of Pain Management in Schwannomatosis: A Literature Review.

Hino U, Tamura R, Toda M Ther Clin Risk Manag. 2025; 21():61-68.

PMID: 39839825 PMC: 11748755. DOI: 10.2147/TCRM.S362794.


Phenotypic Expansion of Autosomal Dominant -Related Disorders with Special Emphasis on Adult-Onset Features.

Uliana V, Ambrosini E, Taiani A, Cesarini S, Cannizzaro I, Negrotti A Genes (Basel). 2024; 15(7.

PMID: 39062695 PMC: 11276570. DOI: 10.3390/genes15070916.


Screening of potential novel candidate genes in schwannomatosis patients.

Perez-Becerril C, Wallace A, Schlecht H, Bowers N, Smith P, Gokhale C Hum Mutat. 2022; 43(10):1368-1376.

PMID: 35723634 PMC: 9540472. DOI: 10.1002/humu.24424.


Clinical characteristics and genetic testing outcome of suspected hereditary peripheral nerve sheath tumours in a tertiary cancer institution in Singapore.

Loh J, Ong P, Goh D, Puhaindran M, Vellayappan B, Ow S Hered Cancer Clin Pract. 2022; 20(1):23.

PMID: 35698239 PMC: 9195433. DOI: 10.1186/s13053-022-00230-4.


Comparison of the frequency of loss-of-function LZTR1 variants between schwannomatosis patients and the general population.

Deng F, Evans D, Smith M Hum Mutat. 2022; 43(7):919-927.

PMID: 35391499 PMC: 9324957. DOI: 10.1002/humu.24376.